Home
Scholarly Works
Patient-Reported Quality of Life (QoL) Following...
Conference

Patient-Reported Quality of Life (QoL) Following Tisagenlecleucel Infusion in Adult Patients with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

Authors

Maziarz RT; Bishop MR; Tam CS; Borchmann P; Jaeger U; McGuirk J; Waller EK; Jaglowski S; Andreadis C; Foley SR

Volume

53

Pagination

pp. 177-178

Publisher

NATURE PUBLISHING GROUP

Publication Date

September 1, 2018

Name of conference

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)

Conference place

Lisbon, PORTUGAL

Conference start date

March 18, 2018

Conference end date

March 21, 2018

Conference proceedings

BONE MARROW TRANSPLANTATION

ISSN

0268-3369

Contact the Experts team